Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Commentaries on Cutting Edge Science

Vascular Niche Controls Organ Regeneration

Yosif Manavski, Reinier A. Boon, Stefanie Dimmeler
Download PDF
https://doi.org/10.1161/CIRCRESAHA.114.303452
Circulation Research. 2014;114:1077-1079
Originally published March 27, 2014
Yosif Manavski
From the Institute of Cardiovascular Regeneration, Centre of Molecular Medicine, J.W. Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinier A. Boon
From the Institute of Cardiovascular Regeneration, Centre of Molecular Medicine, J.W. Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Dimmeler
From the Institute of Cardiovascular Regeneration, Centre of Molecular Medicine, J.W. Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Introduction
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Introduction

Endothelial Cell-Derived Angiopoietin-2 Controls Liver Regeneration as a Spatiotemporal Rheostat

Hu et al

Science. 2014;343:416–419.

Vessels provide the conduits that deliver metabolites and oxygen to the tissue and export waste products. After ischemia or tissue injury, endothelial cells migrate and proliferate to re-establish the capillary network in a process termed angiogenesis to maintain oxygen supply. Besides these essential and well-established functions in oxygen delivery, recent studies suggest that endothelial cells contribute to the multicellular-crosstalk that balances regeneration and dysfunctional or maladaptive healing. Thus, endothelial cells not only seem important for oxygen delivery but act as paracrine source for signals that determine tissue regeneration versus fibrosis. The interaction of endothelial-derived signals with hepatocyte functions has already been shown in the development of model organisms such as zebrafish1 and more recently during regeneration of lung and liver in adult mice.2,3

Two recent studies provide novel important insights into the regulation and nature of the endothelial-derived signals that control liver regeneration.4,5 The liver is a highly regenerative organ and as such well suited to defining the signals that control proliferation of hepatocytes to restore liver function and prevent maladaptive responses that cause liver fibrosis and finally liver failure. In a recent elegant study in Science, Hu et al5 report a critical role of angiopoietin-2 (Ang2) in liver regeneration. Ang2 acts as contextual antagonist of the vascular receptor tyrosine kinase Tie2 and was identified by Hu et al5 among the most profoundly downregulated genes during liver regeneration. To explore the function of Ang2 in liver regeneration, Ang2−/− mice were partially hepatectomized and liver regeneration was time-dependently analyzed. Within the first days, Ang2−/− mice showed significantly increased proliferation of hepatocytes demonstrating that Ang2 downregulation releases a paracrine growth regulatory brake on hepatocytes at the early inductive stages of liver regeneration. Extensive analysis of potential mechanisms that mediate the inhibitory effects of Ang2 revealed that this is likely mediated via an indirect effect on transforming growth factor (TGF)-β1, which was reduced in Ang2−/− mice. Consistently, neutralizing antibodies directed against TGF-β increased the liver sinusoidal endothelial cell–mediated paracrine induction of hepatocyte proliferation in vitro. Together, these data demonstrate that at early stages of liver regeneration, inhibition of Ang2-dependent TGF-β production enhances hepatocyte proliferation and regeneration (Figure [A]).

Figure.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure.

The vascular niche in liver regeneration. A, Summary of proposed angiopoietin-2 (Ang2) effects in liver regeneration. Ang2 downregulation during early time points results in increased hepatocyte proliferation and regeneration. Ang2 upregulation at later stages is required for angiogenesis. B, Crosstalk of stromal-derived factor-1–dependent and Ang2-dependent signaling in endothelial cells with hepatocytes. A change in CXCR4/CXCR7 ratio toward increased CXCR7 activity promotes liver regeneration. EC indicates endothelial cell; HGF, hepatocyte growth factor; LSEC, liver sinusoidal endothelial cell; TGF, transforming growth factor; and VEGFR2, vascular endothelial growth factor receptor 2.

However, when the authors analyzed hepatocyte proliferation in Ang2−/− mice at later time points after partial hepatectomy, a different picture emerged: whereas proliferation was increased during the inductive phase (days 0–3), after day 4 hepatocyte proliferation and liver weight were significantly reduced, implicating that Ang2 is required for liver regeneration at later time points.5 This is consistent with the timing of Ang2 expression, which was profoundly reduced at days 1 to 2 but is re-established 4 days after injury. To identify the mechanism underlying the late impairment of liver regeneration in Ang2−/− mice, the authors determined an influence on the stromal cell population and showed that liver sinusoidal endothelial cell proliferation and vascular endothelial growth factor receptor 2 expression were markedly reduced in Ang2−/− mice 4 days after partial hepatectomy. Indeed, inhibition of Ang2 reduced vascular endothelial growth factor receptor 2 expression and angiogenic functions of endothelial cells in vitro, suggesting that Ang2 is required for the angiogenic phase during liver regeneration. Together, these data strongly point to a critical influence of the timing of expression of the angiocrine factor Ang2 in liver regeneration.

Recently, Ding et al4 highlighted the important role of another paracrine factor, the stromal-derived factor-1 (chemokine [C-X-C motif] ligand 12), and its receptors in liver regeneration. The group showed that the endothelial stromal-derived factor-1 receptors, C-X-C motif receptor 4 (CXCR4), C-X-C motif receptor 7 (CXCR7), modulate the balance between regeneration and liver fibrosis (Figure [B]). CXCR4 was the first identified receptor for the potent chemokine stromal-derived factor-1 and only recently a second receptor, namely CXCR7, gained increasing attention as it binds to stromal-derived factor-1 with even higher affinity.6 Both receptors are highly expressed in endothelial cells. Using endothelial-specific deletion strategies, Ding et al now made the surprising findings that only CXCR7 is required for hepatocyte proliferation and regeneration after acute carbon tetrachloride–induced liver injury. Moreover, pharmacological activation of CXCR7 prevented liver fibrosis in chronic injury models induced by iterative hepatotoxin injection and bile duct ligation. Interestingly, the CXCR4 receptor seems to counteract this proregenerative activity and its deletion in endothelial cells reduced TGF-β expression and prevented liver fibrosis in chronic models. The counteracting role of CXCR4 versus CXCR7 was mirrored by a striking time-dependent differential regulation of the receptors: CXCR7 was rapidly upregulated within 3 days after injury, whereas CXCR4 expression increased at >2 weeks after injury. Both studies identify TGF-β as profibrotic paracrine factor and it will be important to identify the specific proregenerative paracrine cocktail responsible for organ regeneration.

What do we learn from these studies? The endothelial response to injury critically regulates regeneration—at least in the liver. Thereby, the spatiotemporal control of endothelial cell intrinsic properties and paracrine activity is critical in modulating the different phases of regeneration. When considering the development of therapeutic strategies targeting growth factors to enhance regeneration and prevent maladaptive healing, the timing might be crucial. This may not be fully unexpected, considering, for example, the well-known biphasic activities of growth factors such as Wnts during differentiation7 or the double-edged role of inflammation in repair/regeneration.8 However, the recent studies now show that the endothelium independent of its function in oxygen delivery may act as either a proregenerative or a profibrotic niche, depending on the context.

Do these studies implicate a general role of endothelial cell paracrine activities in organ repair and regeneration? To date, the concept was validated for the liver, and to some extent to the lung, and several lines of evidence argue for a role of the vascular niche in the maintenance and regulation of hematopoietic stem cells in the bone marrow.9 Whether a similar concept may be relevant for the heart, which possesses a much lower endogenous regenerative activity, is unclear and deserves further studies. Several previous findings may suggest the existence of similar cell-to-cell communication scenarios in the heart as well: first, a disruption of the angiogenic response and angiocrine signal of endothelial cells was shown to lead to a transit from hypertrophy to heart failure in mice models.10–12 Second, the paracrine activity of various progenitor and proangiogenic cells was shown to not only preserve cardiac myocyte survival but also contribute to myocyte replacement.13,14 Because bone marrow–derived cell populations and cardiac stem cells have been shown to affect angiogenesis and endothelial cell function in mice and humans,15,16 one may speculate that these activities may have contributed to the balance between regeneration/repair and dysfunctional healing leading to fibrosis. Third, studies in patients with dilative cardiomyopathy demonstrated that an impaired microcirculatory response is associated with a poor prognosis.17 Finally, conceptually, endothelial cells may be well suited to act as a paracrine reservoir because they contribute to all organs and can easily sense injuries. Of note, the well-known organ-specific features of endothelial cells may include a selective pattern of released paracrine factors that appropriately support organ healing and functions. Further insights into the multicellular-crosstalk of endothelial cells that balances regeneration versus maladaptive healing may not only provide a better understanding of the mechanisms but may help to develop better fine-tuned proangiogenic therapies.

Sources of Funding

The authors are supported by the European Union (FP7 project Endostem 241440).

Disclosures

Dr Dimmeler is founder and shareholder of t2Cure GmbH. The other authors report no conflicts.

Footnotes

  • The opinions expressed in this Commentary are not necessarily those of the editors or of the American Heart Association.

  • Commentaries serve as a forum in which experts highlight and discuss articles (published here and elsewhere) that the editors of Circulation Research feel are of particular significance to cardiovascular medicine.

  • Commentaries are edited by Aruni Bhatnagar & Ali J. Marian.

  • © 2014 American Heart Association, Inc.

References

  1. 1.
    1. Sakaguchi TF,
    2. Sadler KC,
    3. Crosnier C,
    4. Stainier DY
    . Endothelial signals modulate hepatocyte apicobasal polarization in zebrafish. Curr Biol. 2008;18:1565–1571.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Ding BS,
    2. Nolan DJ,
    3. Guo P,
    4. Babazadeh AO,
    5. Cao Z,
    6. Rosenwaks Z,
    7. Crystal RG,
    8. Simons M,
    9. Sato TN,
    10. Worgall S,
    11. Shido K,
    12. Rabbany SY,
    13. Rafii S
    . Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell. 2011;147:539–553.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ding BS,
    2. Nolan DJ,
    3. Butler JM,
    4. James D,
    5. Babazadeh AO,
    6. Rosenwaks Z,
    7. Mittal V,
    8. Kobayashi H,
    9. Shido K,
    10. Lyden D,
    11. Sato TN,
    12. Rabbany SY,
    13. Rafii S
    . Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310–315.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ding BS,
    2. Cao Z,
    3. Lis R,
    4. Nolan DJ,
    5. Guo P,
    6. Simons M,
    7. Penfold ME,
    8. Shido K,
    9. Rabbany SY,
    10. Rafii S
    . Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature. 2014;505:97–102.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Hu J,
    2. Srivastava K,
    3. Wieland M,
    4. Runge A,
    5. Mogler C,
    6. Besemfelder E,
    7. Terhardt D,
    8. Vogel MJ,
    9. Cao L,
    10. Korn C,
    11. Bartels S,
    12. Thomas M,
    13. Augustin HG
    . Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343:416–419.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Singh AK,
    2. Arya RK,
    3. Trivedi AK,
    4. Sanyal S,
    5. Baral R,
    6. Dormond O,
    7. Briscoe DM,
    8. Datta D
    . Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev. 2013;24:41–49.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Ueno S,
    2. Weidinger G,
    3. Osugi T,
    4. Kohn AD,
    5. Golob JL,
    6. Pabon L,
    7. Reinecke H,
    8. Moon RT,
    9. Murry CE
    . Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:9685–9690.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Duffield JS,
    2. Forbes SJ,
    3. Constandinou CM,
    4. Clay S,
    5. Partolina M,
    6. Vuthoori S,
    7. Wu S,
    8. Lang R,
    9. Iredale JP
    . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115:56–65.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Dimmeler S
    . Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol. 2010;30:1088–1093.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Shiojima I,
    2. Sato K,
    3. Izumiya Y,
    4. Schiekofer S,
    5. Ito M,
    6. Liao R,
    7. Colucci WS,
    8. Walsh K
    . Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108–2118.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Sano M,
    2. Minamino T,
    3. Toko H,
    4. et al
    . p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444–448.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. May D,
    2. Gilon D,
    3. Djonov V,
    4. Itin A,
    5. Lazarus A,
    6. Gordon O,
    7. Rosenberger C,
    8. Keshet E
    . Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc Natl Acad Sci USA. 2008;105:282–287.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Loffredo FS,
    2. Steinhauser ML,
    3. Gannon J,
    4. Lee RT
    . Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011;8:389–398.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Malliaras K,
    2. Zhang Y,
    3. Seinfeld J,
    4. Galang G,
    5. Tseliou E,
    6. Cheng K,
    7. Sun B,
    8. Aminzadeh M,
    9. Marbán E
    . Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med. 2013;5:191–209.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Silvestre JS
    . Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases. Thromb Res. 2012;130(Suppl 1):S90–S94.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Erbs S,
    2. Linke A,
    3. Schächinger V,
    4. Assmus B,
    5. Thiele H,
    6. Diederich KW,
    7. Hoffmann C,
    8. Dimmeler S,
    9. Tonn T,
    10. Hambrecht R,
    11. Zeiher AM,
    12. Schuler G
    . Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation. 2007;116:366–374.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Neglia D,
    2. Michelassi C,
    3. Trivieri MG,
    4. Sambuceti G,
    5. Giorgetti A,
    6. Pratali L,
    7. Gallopin M,
    8. Salvadori P,
    9. Sorace O,
    10. Carpeggiani C,
    11. Poddighe R,
    12. L’Abbate A,
    13. Parodi O
    . Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–193.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
March 28, 2014, Volume 114, Issue 7
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Introduction
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Vascular Niche Controls Organ Regeneration
    Yosif Manavski, Reinier A. Boon and Stefanie Dimmeler
    Circulation Research. 2014;114:1077-1079, originally published March 27, 2014
    https://doi.org/10.1161/CIRCRESAHA.114.303452

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Vascular Niche Controls Organ Regeneration
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Vascular Niche Controls Organ Regeneration
    Yosif Manavski, Reinier A. Boon and Stefanie Dimmeler
    Circulation Research. 2014;114:1077-1079, originally published March 27, 2014
    https://doi.org/10.1161/CIRCRESAHA.114.303452
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Vascular Biology

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured